98%
921
2 minutes
20
Recently, tumor budding (TB) has been suggested as a strong prognostic marker in urinary tract urothelial carcinoma (UC). The aim of this systematic review is to test the prognostic value of TB in UC by a meta-analysis of previously published studies. We systematically reviewed the literature related to TB by using the databases of Scopus, PubMed, and Web of Science. The search was limited to publications in the English language up to July 2022. There were 790 patients from 7 retrospective studies in which TB has been evaluated in UC. Two authors independently extracted the results from eligible studies. The meta-analysis of eligible studies revealed that TB is a significant prognosticator for progression-free survival in UC, with a hazard ratio (HR) of 3.51 (95% CI, 1.86-6.62; P < .001) in univariate analysis and a HR of 2.78 (95% CI, 1.57-4.93; P < .001) in multivariate analysis; a significant prognosticator for overall survival and cancer-specific survival in UC, with a HR of 3.07 (95% CI, 2.04-4.64; P < .001) and a HR of 2.18 (95% CI, 1.11-4.29; P = .02) respectively in univariate analysis. Our findings confirm that UC with a high TB count is at a high risk of progress. TB could be considered as an element in pathology reports and future oncologic staging systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.labinv.2023.100136 | DOI Listing |
Cancer Lett
September 2025
Cancer Center, Shanghai General Hospital of Nanjing Medical University, Shanghai, China; Shanghai Key Laboratory for Pancreatic Diseases and Cancer Center, Shanghai, China. Electronic address:
Radiotherapy, a pivotal treatment for colorectal cancer, is compromised by tumor repopulation, which is characterized by accelerated growth and increased treatment resistance. Although radiation-induced DNA breaks eliminate most cells, a subset of polyploid giant cancer cells (PGCCs) evade death through massive genomic amplification, subsequently undergoing depolyploidization via a viral budding-like process to generate proliferative progeny. Critically, these PGCCs drive tumor repopulation and underpin therapeutic failure.
View Article and Find Full Text PDFArkh Patol
September 2025
Lomonosov Moscow State University, Medical Research and Educational Institute, Moscow, Russia.
Objective: To detect the presence or absence of correlations between the degree of tumor budding (TB) and pMMR/dMMR (proficient Mismatch Repair System/deficient Mismatch Repair System) and PD-L1 status in gastric cancer (GC).
Material And Methods: Surgical material from 173 patients with verified gastric cancer of the tubular histological subtype, where the invasive edge of the carcinoma was examined, tumor budding were identified and counted by three methods: H. Ueno, L.
Hum Pathol
August 2025
Department of Radiation Oncology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow- 226010.
Background: Programmed death ligand 1 (PD-L1) is essential for immune evasion and serves as a significant biomarker for immunotherapy in oral squamous cell carcinoma (OSCC). Nevertheless, the changes in its expression after neoadjuvant chemotherapy (NACT) are not well understood. This research sought to assess the variations in PD-L1 expression between matched pretreatment biopsy samples and post-NACT surgical specimens, while also correlating these results with clinicopathological characteristics.
View Article and Find Full Text PDFJ Gastrointest Cancer
August 2025
Department of General Surgery, Coloproctology Unit, Hospital Universitario de Navarra, Hospital Universitario de Navarra, Pamplona, Spain.
Introduction: Colorectal cancer (CRC) is a leading cause of cancer-related mortality in Spain, with pT1 adenocarcinomas often managed via endoscopic polypectomy (EP). Determining the necessity of additional surgery post-EP remains challenging, especially given the low incidence of intramural residual tumor (IRT) and lymph node metastasis (LNM) in certain high-risk cases. This study aims to evaluate histological factors predicting residual disease and to explore strategies to reduce unnecessary completion surgeries.
View Article and Find Full Text PDFVet J
October 2025
Laboratory of Veterinary Internal Medicine, Graduate School of Agricultural and Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Gallbladder mucocele (GBM) is one of the most common gallbladder disorders in dogs. Recent studies have suggested a potential association between GBM development and reduced expression of anion channel-related molecules in gallbladder epithelial cells. However, further investigation has been limited due to the lack of an effective in vitro culture system to validate the functions of the molecules.
View Article and Find Full Text PDF